Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology.

This activity is designed for radiation oncologists, focusing on managing bone metastases. One of the three presentations exclusively explores stereotactic body radiation therapy (SBRT) for non-spinal bone metastases. Supporting data guides discussions on SBRT's effectiveness and strategies.

This activity explores the use of repeat radiation for intra-cranial neoplasms. Radiation is the primary management modality for the treatment of a number of intracranial pathologies and the initial treatment is well studied and relatively standardized across the specialty.

This activity involves three discussants using case-based presentations to review challenging areas of breast cancer management. The first discussant examines the options for treating patients with recurrent breast cancer.

The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.

Breast cancer is the most diagnosed cancer in women. The most commonly diagnosed form of breast cancer in the United States is early-stage breast cancer, for which there are outstanding outcomes.

Lung cancer screening is resulting in a higher incidence of early-stage lung cancer diagnoses. This commonly occurs among older patients with chronic lung disease who are at high risk for complications with attaining pathologic confirmation.

There are many advances in the application of artificial intelligence (AI) in contouring and segmentation, as well as patient specific quality assurance.